Patient preferences for the treatment of systemic sclerosis-associated interstitial lung disease: a discrete choice experiment.

Cosimo BruniSebastian HeidenreichAshley DuenasAnna-Maria Hoffmann-VoldArmando GabrielliYannick AllanoreEmmanuel ChatelusJörg H W DistlerEric HachullaVivien M HsuNicolas HunzelmannDinesh KhannaMarie-Elise TruchetetUlrich A WalkerMargarida AlvesNils SchoofLesley Ann SaketkooOliver Distler

Published in: Rheumatology (Oxford, England) (2022)

This is the first study to quantitatively elicit patients' preferences for treatment attributes in SSc-ILD. Patients showed willingness to make trade-offs, providing a firm basis for shared decision-making in clinical practice.

Keyphrases

interstitial lung disease
systemic sclerosis
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
clinical practice
rheumatoid arthritis
prognostic factors
idiopathic pulmonary fibrosis
peritoneal dialysis
patient reported outcomes
patient reported
smoking cessation